Company also completes Phase 1 epithelial study to evaluate the safety of topical TTHX1114 to reduce the duration and impact of corneal epithelial defects SAN DIEGO--(BUSINESS WIRE)--Trefoil ...
SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, Inc. (Aurion Biotech), whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today ...
Please provide your email address to receive an email when new articles are posted on . Many years of research led to the approval of a breakthrough cell therapy for corneal endothelial dysfunction in ...
Corneal transplantation using donor tissue is currently the primary treatment for corneal endothelial insufficiency. Despite the potential for vision restoration through corneal transplantation, there ...
In 1910, Professor Ernst Fuchs, an Austrian ophthalmologist, published an article describing 13 patients with Fuchs’ dystrophy, a condition in the cornea that subsequently bears his name. The patients ...
Gordon-Weiss-Schanzlin Vision Institute in San Diego announced that its eye surgeon, David J. Schanzlin, MD, recently performed the first corneal transplant during endothelial keratoplasty surgery ...
Many eye banks won't accept corneas from donors with diabetes, concerned they might be harder to prepare for transplant surgery or are more likely to fail. Subscribe to our newsletter for the latest ...
Many eye banks won’t accept corneas from donors with diabetes, concerned they might be harder to prepare for transplant surgery or are more likely to fail. “We also found the severity of the donor’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback